Shopping Cart 0
Cart Subtotal
USD 0

DexCom Inc (DXCM) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company's major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring systems. DexCom's in-hospital product, GlucoClear, is a blood-based in-vivo automated glucose monitoring system. It also provides training and support services. DexCom offer its products to endocrinologists, physicians, diabetes educators and others. The company distributes its products in the US, Canada, Australia, New Zealand, Europe, Asia, Latin America and the Middle East through direct sales force and a network of distributors. DexCom is headquartered in San Diego, California, the US.

DexCom Inc (DXCM)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

DexCom Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

DexCom Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

DexCom Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

DexCom Inc, Medical Equipment, Deal Details 12

Venture Financing 12

DexCom Raises USD7.2 Million in Venture Financing 12

TypeZero Technologies Raises Funds through Seed Financing 13

Partnerships 14

TypeZero Technologies and EOFlow Enter into Licensing Agreement 14

Senseonics Enters into Licensing Agreement with TypeZero Tech 15

Cellnovo Enters into Licensing Agreement with TypeZero Tech 16

Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 17

Dexcom Amends Licensing Agreement with Google Life Sciences 18

Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 19

Tandem Diabetes Amends Licensing Agreement With DexCom 20

Novo Nordisk Forms Partnership with Dexcom and Glooko 21

Terumo Enters into Distribution Agreement with DexCom 22

DexCom Enters into Agreement with Eli Lilly 23

Fitbit Forms Partnership with DexCom 24

Senseonics Holdings Enters into Agreement with TypeZero and Roche Diabetes 25

Ascensia Diabetes Care Enters into Agreement with DexCom 26

Apple Enters into Agreement with DexCom 27

Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 28

Glooko Enters into Agreement with Dexcom 29

Julphar Enters Into Co-Marketing Agreement With Dexcom 30

Debt Offering 31

DexCom Raises USD350 Million in Private Placement of 0.75% Notes Due 2022 31

Acquisition 32

DexCom Acquires TypeZero Technologies 32

DexCom to Acquire Nintamed 33

DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To USD8.5 Million 34

DexCom Inc-Key Competitors 35

DexCom Inc-Key Employees 36

DexCom Inc-Locations And Subsidiaries 37

Head Office 37

Other Locations & Subsidiaries 37

Recent Developments 38

Financial Announcements 38

Aug 01, 2018: DexCom Reports Second Quarter 2018 Financial Results 38

Feb 27, 2018: DexCom Reports Record Fourth Quarter and Fiscal Year 2017 Financial Results 39

Nov 01, 2017: DexCom Reports Record Third Quarter 2017 Financial Results 41

Aug 01, 2017: DexCom Reports Second Quarter 2017 Financial Results 42

May 02, 2017: DexCom Reports First Quarter 2017 Financial Results 43

Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results 44

Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook 45

Corporate Communications 46

Aug 01, 2018: DexCom Executive Chairman and Director Terry Gregg Retires 46

Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors 47

Legal and Regulatory 48

Jun 05, 2018: Federal Court Judge Awards AgaMatrix Attorneys' Fees While Admonishing Dexcom for "Bad Faith" Lawsuit 48

Product News 49

Aug 21, 2017: New Study Shows People with Type 2 Diabetes Benefit from Continuous Glucose Monitoring 49

Jun 09, 2017: New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Daily Injections Benefit from CGM 50

Other Significant Developments 52

Sep 19, 2017: DexCom Opens Data Platform and Launches Developer Program to Fuel Diabetes App Innovation 52

Sep 07, 2017: Fitbit and Dexcom to Develop Continuous Glucose Monitoring Experience for People Living with Diabetes 53

Jun 01, 2017: Glooko and Dexcom Expand Relationship With Global Cloud Sharing Data Agreement 54

May 08, 2017: Dexcom Continuous Glucose Monitoring now available on the Government Subsidy Initiative 55

Appendix 56

Methodology 56

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

DexCom Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

DexCom Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

DexCom Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

DexCom Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

DexCom Inc, Medical Equipment, Key Facts, 2017 2

DexCom Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

DexCom Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

DexCom Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

DexCom Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

DexCom Inc, Deals By Market, 2012 to YTD 2018 9

DexCom Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

DexCom Raises USD7.2 Million in Venture Financing 12

TypeZero Technologies Raises Funds through Seed Financing 13

TypeZero Technologies and EOFlow Enter into Licensing Agreement 14

Senseonics Enters into Licensing Agreement with TypeZero Tech 15

Cellnovo Enters into Licensing Agreement with TypeZero Tech 16

Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies 17

Dexcom Amends Licensing Agreement with Google Life Sciences 18

Tandem Expands Licensing Agreement With Dexcom For Glucose Monitoring System 19

Tandem Diabetes Amends Licensing Agreement With DexCom 20

Novo Nordisk Forms Partnership with Dexcom and Glooko 21

Terumo Enters into Distribution Agreement with DexCom 22

DexCom Enters into Agreement with Eli Lilly 23

Fitbit Forms Partnership with DexCom 24

Senseonics Holdings Enters into Agreement with TypeZero and Roche Diabetes 25

Ascensia Diabetes Care Enters into Agreement with DexCom 26

Apple Enters into Agreement with DexCom 27

Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 28

Glooko Enters into Agreement with Dexcom 29

Julphar Enters Into Co-Marketing Agreement With Dexcom 30

DexCom Raises USD350 Million in Private Placement of 0.75% Notes Due 2022 31

DexCom Acquires TypeZero Technologies 32

DexCom to Acquire Nintamed 33

DexCom Completes Acquisition Of SweetSpot Diabetes Care For Up To USD8.5 Million 34

DexCom Inc, Key Competitors 35

DexCom Inc, Key Employees 36

DexCom Inc, Subsidiaries 37

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

DexCom Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.